Internal Medicine, Gastroenterology · Cleveland, OH
NPI
1467417261
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
9500 Euclid Ave
Cleveland, OH, 44195
Phone (800) 223-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
521 services
Medicare patients, 2024
246
Average age 71
Drug cost, 2024
$6.8M
1,203 prescriptions
Company payments, 2025
$112
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jean-Paul Achkar was code G0500 (moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito), 97 times for 95 patients. In total Jean-Paul Achkar billed 521 services in 35 codes, and Medicare paid $32K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-25.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 97 | 95 | $4.32 | $419 |
| 45380 Lower GI Endoscopy - Other | Facility | 47 | 46 | $83.80 | $3,939 |
| 99213 Office E&M - Established | Office | 39 | 37 | $56.87 | $2,218 |
| 99213 Office E&M - Established | Facility | 39 | 39 | $44.71 | $1,744 |
| 99214 Office E&M - Established | Facility | 38 | 35 | $62.46 | $2,373 |
| 99214 Office E&M - Established | Office | 32 | 28 | $88.41 | $2,829 |
| 45385 Colonoscopy - Lesion Removal | Facility | 32 | 32 | $196.18 | $6,278 |
| 99232 Hospital E&M - Subsequent | Facility | 28 | 24 | $59.68 | $1,671 |
| 43239 Upper GI Endoscopy | Facility | 19 | 19 | $75.59 | $1,436 |
| 99233 Hospital E&M - Subsequent | Facility | 19 | 18 | $86.69 | $1,647 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 14 | 14 | $12.49 | $175 |
| 44380 Digestive/Gastrointestinal | Facility | 13 | 11 | $34.69 | $451 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 12 | 12 | $12.49 | $150 |
By year: 2022 $31K for 487 services; 2023 $28K for 450 services; 2024 $32K for 521 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jean-Paul Achkar prescribed most often to Medicare patients was Stelara (Ustekinumab), with 169 prescriptions and refills. In total Jean-Paul Achkar wrote 1,203 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 169 | 234 | 27 | $4.8M |
| Omeprazole Generic | 104 | 207 | 28 | $1,785 |
| Humira(Cf) Pen Adalimumab | 94 | 95 | Under 11 | $1.0M |
| Mesalamine Generic | 90 | 151 | 26 | $51K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 68 | 72 | 17 | $3,430 |
| Loperamide Loperamide Hcl | 62 | 109 | 17 | $2,968 |
| Dicyclomine Hcl Generic | 45 | 57 | 15 | $913 |
| Balsalazide Disodium Generic | 39 | 83 | 11 | $9,542 |
| Prednisone Generic | 38 | 44 | 15 | $355 |
| Pantoprazole Sodium Generic | 37 | 77 | Under 11 | $228 |
| Mesalamine Er Mesalamine | 34 | 70 | 11 | $8,667 |
| Humira Pen Adalimumab | 24 | 24 | Under 11 | $194K |
| Entyvio Vedolizumab | 21 | 27 | Under 11 | $187K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 18 | 18 | 17 | $256 |
| Esomeprazole Magnesium Generic | 18 | 20 | Under 11 | $202 |
Brand drugs: 458 claims; generic drugs: 729 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jean-Paul Achkar $112 ($112 in general payments such as food, travel and fees) from 3 companies. The largest payer was Pfizer Inc. with $78.64.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.